#FDAFastTrack
LightNews LightNews
theminingnews.bsky.social
🚀 Zacks Small Cap Research - COCP: $5 Million Private Placement with OPKO Health
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-cocp-5-million-private-placement-with-opko-health/
#Cocrystal#CocrystalPharmaI#COCPN#CDI988s#Norovirus##Phase1br#FDAFastTrackt#Prihashtag/OPKOHealth" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#OPKOHealth
August 20, 2026 at 8:06 PM
figsdee.bsky.social
The Congo
#USColonist
#Genocide
#JoeRogan&Investors
#FDAFastTrack
www.youtube.com/shorts/tJvVN...
A Sacred Plant, A Global Industry… Who Pays the Price?
YouTube video by Shanell Oliver
www.youtube.com
May 3, 2026 at 11:23 PM
oregonbioincubator.bsky.social
🚨 Final Session Alert! 🚨

Join us Tue, July 15 | 12–1 PM (PDT) on Zoom for FDA Programs to Expedite Drug Development with Elizabeth Gordon, sponsored by RAIN Catalysts.

Free to attend. Register now: zurl.co/nR7ku

#FDAFastTrack #DrugDevelopment #BiotechEvents
July 1, 2025 at 4:56 PM
d-and-d-world.bsky.social
Enterome’s OncoMimics immunotherapy EO2463 gains FDA Fast Track for follicular lymphoma, paving the way for Phase III trials in in the low-tumor-burden “watch-and-wait” setting.

#News #Lymphoma #FDAfasttrack #CancerResearch #Enterome #Oncology
Enterome’s lymphoma drug wins FDA fast track designation
The company is exploring EO2463’s efficacy in relapsed or refractory settings in a Phase I/II trial, with plans to start Phase III registrational trial in a “watch-and-wait” iNHL patient population
druganddeviceworld.com
October 21, 2025 at 1:16 PM
d-and-d-world.bsky.social
Cereno Scientific secures FDA Fast Track designation for its PAH drug CS1, advancing toward a Phase IIb trial. A key step in bringing new treatment options to patients with urgent unmet needs. 🚀💊

#News #FDAFastTrack #PAH #Biotech #RareDisease #DrugDevelopment #CerenoScientific
US FDA fast-tracks Cereno Scientific’s PAH drug CS1
Cereno Scientific is preparing for a global Phase IIb trial for CS1, scheduled to begin in the first half of 2026.
druganddeviceworld.com
August 27, 2025 at 7:52 PM
phalguniddw.bsky.social
Enterome’s OncoMimics immunotherapy EO2463 gains FDA Fast Track for follicular lymphoma, paving the way for Phase III trials in in the low-tumor-burden “watch-and-wait” setting.

#News #Lymphoma #FDAfasttrack #CancerResearch #Enterome #Oncology
Enterome’s lymphoma drug wins FDA fast track designation
The company is exploring EO2463’s efficacy in relapsed or refractory settings in a Phase I/II trial, with plans to start Phase III registrational trial in a “watch-and-wait” iNHL patient population
druganddeviceworld.com
October 21, 2025 at 1:16 PM
phalguniddw.bsky.social
Cereno Scientific secures FDA Fast Track designation for its PAH drug CS1, advancing toward a Phase IIb trial. A key step in bringing new treatment options to patients with urgent unmet needs. 🚀💊

#News #FDAFastTrack #PAH #Biotech #RareDisease #DrugDevelopment #CerenoScientific
US FDA fast-tracks Cereno Scientific’s PAH drug CS1
Cereno Scientific is preparing for a global Phase IIb trial for CS1, scheduled to begin in the first half of 2026.
druganddeviceworld.com
August 27, 2025 at 7:52 PM
longevitytech.bsky.social
FDA designation accelerates development of a novel ALS treatment that targets disease biology, not just symptoms.

longevity.technology/news/vectory...

#longevity #ALS #neurodegeneration #FDAFastTrack #diseasemodifying #biotech #healthinnovation
January 8, 2026 at 8:13 PM